Patents by Inventor Herman Ng

Herman Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9540332
    Abstract: The present invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof; wherein R, R1, R2, R3, R4, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: January 10, 2017
    Assignee: ALLERGAN, INC.
    Inventors: George R. Ehring, Ellen Chao, Herman Ng, Hau Ton, Jia Chian Li, Joseph S. Adorante, Michael E. Garst, Howard B. Rind, Mark R. Hansen, Alfred Arthur Avey, Jr., Lloyd Jay Dolby, Shervin Esfandiari, Vivian R. MacKenzie, Jeremiah Andrew Marsden, David Charles Muchmore
  • Publication number: 20160355485
    Abstract: The present invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof; wherein R, R1, R2, R3, R4, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.
    Type: Application
    Filed: September 24, 2014
    Publication date: December 8, 2016
    Inventors: George R. Ehring, Ellen Chao, Herman Ng, Hau Ton, Jia Chian Li, Joseph S. Adorante, Michael E. Garst, Howard B. Rind, Mark R. Hansen, Alfred Arthur Avey, JR., Lloyd Jay Dolby, Shervin Esfandiari, Vivian R. MacKenzie, Jeremiah Andrew Marsden, David Charles Muchmore
  • Publication number: 20150011591
    Abstract: The present invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof; wherein R, R1, R2, R3, R4, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Inventors: George R. Ehring, Ellen Chao, Herman Ng, Hau Ton, Jia Chian Li, Joseph S. Adorante, Michael E. Garst, Howard B. Rind, Mark R. Hansen, Alfred Arthur Avey, JR., Lloyd Jay Dolby, Shervin Esfandiari, Vivian R. MacKenzie, Jeremiah Andrew Marsden, David Charles Muchmore
  • Patent number: 8859780
    Abstract: The present invention is directed to a compound of Formula I or a pharmaceutically acceptable salt thereof; wherein R, R1, R2, R3, R4, m, and n are as defined herein, to pharmaceutical compositions comprising said compound, and to methods of treating diseases or conditions mediated by elevated persistent sodium current, such as an ocular disorder, multiple sclerosis, seizure disorder, and chronic pain.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: October 14, 2014
    Assignee: Allergan, Inc.
    Inventors: George R. Ehring, Ellen Chao, Herman Ng, Hau Ton, Jia Chian Li, Joseph S. Adorante, Michael S. Garst, Howard B. Rind, Mark R. Hansen, Alfred Arthur Avey, Jr., Lloyd Jay Dolby, Shervin Esfandiari, Vivian R. MacKenzie, Jeremiah Andrew Marsden, David Charles Muchmore
  • Publication number: 20060172718
    Abstract: A mixer stage is provided that mixes a differential input signal with a differential square-wave signal of an oscillator, having a first amplifier element and a second amplifier element, each of which amplifier elements has a first current connection, a second current connection, and a connection for the differential input signal, having four control elements and also a first output and a second output, wherein the four control elements are modulated in pairs by the differential square-wave signal, thereby connecting each second current connection alternately, and in each case individually, to one of the two outputs. The mixer stage has field-effect transistors as amplifier elements whose first current connections are connected to a constant reference voltage. In addition, a method for mixing frequencies that uses this mixer stage is also disclosed.
    Type: Application
    Filed: January 27, 2006
    Publication date: August 3, 2006
    Applicant: ATMEL GERMANY GMBH
    Inventors: Andreas Leistner, Herman Ng, Hans Sapotta
  • Publication number: 20060164149
    Abstract: A mixer stage is provided that includes an oscillator, a first input, a second input, a first output, a second output, a set of four controllable amplifier elements, and a first current source. The mixer stage further includes at least one second current source in addition to the first current source, the first current source and the at least one second current source can each be switched on and off by an associated switching input that is connected to an associated oscillator output. Pairs of amplifier elements of the set of four together with at least one of the at least two current sources in its switched-on state form a differential amplifier for an input signal present at the first input and the second input. A method for mixing frequencies is also provided.
    Type: Application
    Filed: January 24, 2006
    Publication date: July 27, 2006
    Applicant: ATMEL GERMANY GMBH
    Inventors: Andreas Leistner, Herman Ng, Hans Sapotta